Sweden, 11 April 2024: Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer. Now an extensive Scandinavian study led by researchers at Karolinska Institutet ha......
View Details

Related News

• Use of acid reflux drugs linked to higher risk of migraine (27-04-2024)

---

• Engineered peptides open new avenue for immunotherapy drug development (20-04-2024)

---

• Researchers resolve old mystery of how phages disarm pathogenic bacteria (16-04-2024)

---

• Carbon beads help restore healthy gut microbiome and reduce liver disease progression (15-04-2024)

---

• New microfluidic device improves the separation of tumor cells and clusters from malignant effusions (15-04-2024)

---

• AI makes retinal imaging 100 times faster than manual method (14-04-2024)

---

• Beta-blockers show no benefit for heart attack patients with normal heart function (11-04-2024)

---

• Post-surgery infections may mainly be caused by skin bacteria (11-04-2024)

---

• Many cancer drugs remain unproven 5 yrs after accelerated app (08-04-2024)

---

• Gut bacteria linked to younger colon cancer patients (08-04-2024)

---